Urigen Announces US Patent Office Notice of Allowance of Claims for URG101 (Business Wire via Yahoo! Finance)

Urigen Announces US Patent Office Notice of Allowance of Claims for URG101 (Business Wire via Yahoo! Finance)
BURLINGAME, Calif.—-Urigen Pharmaceuticals, Inc. , http://www.urigen.com announced that the U.S. Patent and Trademark Office issued a notice of allowance for claims for the first patent application for URG101, an investigational, bladder instillation for the treatment of Painful Bladder Syndrome/Interstitial Cystitis .